← Back to Search

ePROMs + Information Hub for Chronic Kidney Failure

N/A
Waitlist Available
Led By Istvan Mucsi
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing maintenance hemodialysis for more than 3 months
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (every 4 weeks, up to 6 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether or not electronic patient reported outcome measures (ePROMs) can help assess and monitor symptoms for patients on maintenance hemodialysis, as well as whether or not a self-management support and decision support information hub can help with symptom management.

Who is the study for?
This trial is for patients who have been on maintenance hemodialysis for over 3 months due to kidney disease. It's not suitable for those with severe acute illnesses, non-English speakers, a life expectancy under 6 months, dementia, or an inability to consent.
What is being tested?
The study tests SUPPORT-DIALYSIS with access to a symptom management website against standard care without this tool. Patients at two dialysis centers will be randomly assigned to either use the ePROMs and information hub or receive the usual treatment.
What are the potential side effects?
Since this trial involves electronic monitoring and informational support rather than medication, traditional side effects are not expected. However, there may be indirect effects related to using technology such as stress or frustration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been on hemodialysis for over 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up (every 4 weeks, up to 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up (every 4 weeks, up to 6 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of Eligible Patients who decline consent
Proportion of Enrolled Patients who Drop-Out From the Study
Proportion of Participants who miss or refuse ePROMs follow-ups
+1 more
Secondary study objectives
Clinical Team Acceptability
Patient Acceptability
Other study objectives
Incidence Rate of Healthcare Use
Disease
Mental Health Component Score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: SUPPORT-DIALYSIS with Access to Output Report and Information HubExperimental Treatment1 Intervention
Feasibility of SUPPORT-Dialysis at Toronto General Hospital
Group II: SUPPORT-DIALYSIS OnlyExperimental Treatment1 Intervention
Usual Treatment at Humber River Hospital

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,523 Previous Clinical Trials
503,302 Total Patients Enrolled
1 Trials studying Kidney Failure
50 Patients Enrolled for Kidney Failure
Humber River HospitalOTHER
5 Previous Clinical Trials
4,341 Total Patients Enrolled
Istvan MucsiPrincipal InvestigatorUniversity Health Network, Toronto
1 Previous Clinical Trials
227 Total Patients Enrolled
~14 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top